Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 1/2017

01-01-2017 | Neurology of Systemic Diseases (J Biller, Section Editor)

Systemic Complications Following Aneurysmal Subarachnoid Hemorrhage

Authors: Ravi Garg, Barak Bar

Published in: Current Neurology and Neuroscience Reports | Issue 1/2017

Login to get access

Abstract

Many systemic complications follow aneurysmal subarachnoid hemorrhage and are primarily due to sympathetic nervous system activation. These complications play an important role in the overall outcome of patients. The purpose of this review is to provide an update on the diagnosis, pathophysiology, and management of systemic complications specifically associated with aneurysmal subarachnoid hemorrhage. Special focus has been made on systemic complications that occur more frequently in patients with aneurysmal subarachnoid hemorrhage compared to other stroke subtypes and in the neurocritical care patient population. These complications include neurogenic pulmonary edema, electrocardiographic changes, troponin elevation, neurogenic stunned myocardium, hyponatremia, and anemia.
Literature
1.
•• Diringer MN, Bleck T, Hemphill C, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40. Print. Diringer et al. as part of the Neurocritical Care Society’s Multidisciplinary Consensus Conference reviewed the literature and provided evidence-based guidelines for the critical care management of patients following aneurysmal subarachnoid hemorrhage.
2.
Chen S, Qian Li WH, Krafft PR, et al. The harmful effects of subarachnoid hemorrhage on extracerebral organs. Biomed Res Int. 2014;2014:1–12. Print.
3.
Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8(3):404–12. Print.CrossRefPubMedPubMedCentral
4.
Davison DL, Chawla LS, Selassie L, et al. Neurogenic pulmonary edema. Chest. 2012;141(3):793–5. Print.CrossRefPubMed
5.
Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):188–92. Print.CrossRefPubMed
6.
Friedman JA, Pichelmann MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52(5):1025–32. Print.PubMed
7.
8.
Fontes RB, Aguiar PH, Zanetti MV, et al. Acute neurogenic pulmonary edema: case reports and literature review. J Neurosurg Anesthesiol. 2003;15(2):144–50. Print.CrossRefPubMed
9.
Sakr YL, Ghosn I, Vincent JL. Cardiac manifestations after subarachnoid hemorrhage: a systematic review of the literature. Prog Cardiovasc Dis. 2002;45(1):67–80. Print.CrossRefPubMed
10.
Goldfinger JZ, Nair A, Sealove BA. Brain-heart interaction in takotsubo cardiomyopathy. Heart Fail Clin. 2013;9(2):217–23. Print.CrossRefPubMed
11.
Lee VH, Oh JH, Mulvagh SL, Wijdicks E. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243–9. Print.CrossRefPubMed
12.
Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36(4):1328–35. Print.CrossRefPubMed
13.
Chatterjee S. ECG changes in subarachnoid haemorrhage: a synopsis. Neth Hear J. 2010;19(1):31–4. Print.CrossRef
14.
Tung P. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35(2):548–51. Print.CrossRefPubMed
15.
Naidech AM. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851–6. Print.CrossRefPubMed
16.
Abd TT, Hayek S, Cheng J, et al. Incidence and clinical characteristics of takotsubo cardiomyopathy post-aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2014;176(3):1362–4. Print.CrossRefPubMed
17.
• Bulsara KR, Mcgirt MJ, Liao L, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(3):524–8. Print. Bulsara et al. retrospectively reviewed 350 patients with aneurysmal subarachnoid hemorrhage and proposed new criteria to differentiate neurogenic stunned myocardium from acute myocardial infarction.
18.
Kurisu S, Kihara Y. Tako-tsubo cardiomyopathy: clinical presentation and underlying mechanism. J Cardiol. 2012;60(6):429–37. Print.CrossRefPubMed
19.
Ancona F, Bertoldi LF, Ruggieri F, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different: table 1. Eur Heart J. 2016. Print.
20.
Yee AH, Burns JD, Wijdicks E. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21(2):339–52. Print.CrossRefPubMed
21.
Mcgirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004;54(6):1369–74. Print.CrossRefPubMed
22.
Mapa B, Taylor BE, Appelboom G, et al. Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg. 2016;85:305–14. Print.CrossRefPubMed
23.
Marik PE. Techniques for assessment of intravascular volume in critically ill patients. J Intensive Care Med. 2009;24(5):329–37. Print.CrossRefPubMed
24.
Moretti R, Pizzi B. Inferior vena cava distensibility as a predictor of fluid responsiveness in patients with subarachnoid hemorrhage. Neurocrit Care. 2010;13(1):3–9. Print.CrossRefPubMed
25.
Filippatos TD, Liamis G, Christopoulou F, Elisaf MS. Ten common pitfalls in the evaluation of patients with hyponatremia. Eur J Intern Med. 2016;29:22–5. Print.CrossRefPubMed
26.
Maesaka JK, Miyawaki N, Palaia T, et al. Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int. 2007;71(8):822–6. Print.CrossRefPubMed
27.
Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14(4):182–7. Print.CrossRefPubMed
28.
• Maesaka JK, Imbriano L, Mattana J, et al. Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia. J Clin Med. 2014;3(4):1373–85. Print. Maesaka et al. reviewed the differences between cerebral salt wasting and SIADH, highlighted the pitfalls of previous diagnostic approaches, and proposed a new volume independent algorithm for the evaluation of hyponatremia.
29.
Pierrakos C, Taccone F, Decaux G, et al. Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience. Ann Intensive Care. 2012;2(1):13. Print.CrossRefPubMedPubMedCentral
30.
Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol. 2008;19(2):194–6. Print.CrossRefPubMed
31.
Naidech AM, Jovanovic B, Wartenberg KE, Parra A, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage*. Crit Care Med. 2007;35(10):2383–9. Print.CrossRefPubMed
32.
• Roux PDL. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):342–53. Print. Roux et al. reviewed 27 articles about the effects of red blood cell transfusion in patients with aneurysmal subarachnoid hemorrhage. Most of the articles were very low quality according to the GRADE criteria. The authors concluded that it is not clear if red blood cell transfusion is a marker of disease severity or independent risk factor for worse outcome.
33.
Stein M, Brokmeier L, Herrmann J, Scharbrodt W, et al. Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction. J Clin Neurosci. 2015;22(3):530–4. Print.CrossRefPubMed
34.
Dhar R, Zazulia AR, Videen TO, et al. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009;40(9):3039–44. Print.CrossRefPubMedPubMedCentral
35.
Smith MJ, Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101(1):1–7. Print.CrossRefPubMed
36.
Kurtz P, Helbok R, Claassen JJ, et al. The effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Neurocrit Care. 2015;24(1):118–21. Print.CrossRef
37.
Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013;79(2):307–12. Print.CrossRefPubMed
Metadata
Title
Systemic Complications Following Aneurysmal Subarachnoid Hemorrhage
Authors
Ravi Garg
Barak Bar
Publication date
01-01-2017
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 1/2017
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-017-0716-3

Other articles of this Issue 1/2017

Current Neurology and Neuroscience Reports 1/2017 Go to the issue

Neuro-Oncology (LE Abrey, Section Editor)

Clinical Relevance of Steroid Use in Neuro-Oncology

Movement Disorders (SH Fox, Section Editor)

Integrating Patient Concerns into Parkinson’s Disease Management

Movement Disorders (SH Fox, Section Editor)

Brain Calcification and Movement Disorders

Movement Disorders (SH Fox, Section Editor)

Autoimmune Movement Disorders: a Clinical and Laboratory Approach

Headache (RB Halker, Section Editor)

When Headache Warns of Homeostatic Threat: the Metabolic Headaches

Neurology of Systemic Diseases (J Biller, Section Editor)

Systemic Complications of Spinal Cord Injury